What we are studying
The purpose of the study is to learn more about a device called the Visualase Thermal Therapy System (Visualase system) and find out if using Visualase is safe and effective for the treatment of people with intractable mesial temporal lobe epilepsy (MTLE).
The study will include approximately 120 adult patients with drug-resistant MTLE treated at selected epilepsy centers across the United States. After the Visualase procedure, patients will be followed for 12 months and evaluated for freedom from seizures, quality of life, adverse events, and neuropsychological outcomes.
$150.00 for the Baseline Visit, $75.00 each for Follow-up Visits 1 and 2 and $150.00 each for Follow-up Visits 3 and 4